|
Status |
Public on Jan 28, 2022 |
Title |
DIPG4_noDOX |
Sample type |
SRA |
|
|
Source name |
DIPG
|
Organism |
Homo sapiens |
Characteristics |
cell line: SU-DIPG-IV antibody: H3K36me3 treatment: Untreated
|
Treatment protocol |
Cells were treated with doxycycline to induce shRNA expression
|
Growth protocol |
Diffuse intrinsic pontine glioma cells (SU-DIPG-IV) were lenti-virally infected with doxycyline inducible shRNA constructs targeting MAT2A followed by antibiotic selection
|
Extracted molecule |
genomic DNA |
Extraction protocol |
Chromatin immunoprecipitations (ChIP), using H3K36me3 antibodies, were carried out using the Diagenode SX-8G IP-Star Compact (Diagenode automated Ideal ChIP-seq Kit). KAPA Hyper prep kit (Cat# KK8504, KAPA Biosystems) and KAPA Dual-indexed adapter kit (Cat# KK8722 KAPA Biosystems) were used to construct the ChIP-RX DNA library for sequencing on an Illumina platform following the manufacturer’s instructions. A
|
|
|
Library strategy |
ChIP-Seq |
Library source |
genomic |
Library selection |
ChIP |
Instrument model |
Illumina NextSeq 500 |
|
|
Data processing |
Reads were trimmed using trimGalore and quality was assessed using FastQC The resulting reads were aligned to hg19 using Bowtie2 (v2.3.5.1) Spike-in normalization was performed by aligning the reads to the dm6 genome. Epic2 was used for peak calling. Genome_build: hg19 Supplementary_files_format_and_content: peak files Supplementary_files_format_and_content: bigwig files
|
|
|
Submission date |
Aug 05, 2021 |
Last update date |
Jan 29, 2022 |
Contact name |
Stephen C Mack |
E-mail(s) |
stephen.mack@stjude.org
|
Organization name |
St. Jude Children’s Research Hospital
|
Street address |
262 Danny Thomas Place
|
City |
Memphis |
State/province |
Tennessee |
ZIP/Postal code |
38105 |
Country |
USA |
|
|
Platform ID |
GPL18573 |
Series (1) |
GSE160006 |
MAT2A and methionine dependency are indispensible for H3K27M mutant gliomas. |
|
Relations |
BioSample |
SAMN20593745 |
SRA |
SRX11657259 |